You will find here news from our Corporate Members.
As a small token of gratitude to frontline health workers fighting the COVID-19 pandemic, RTsafe offers the Remote Film Dosimetry Service free of charge providing the fellow radiotherapy professionals with tangible support.[More information]
Cancer doesn't care about COVID-19: Maintaining cancer treatment regimens in times of crisis is our priority
Long before the start of the COVID-19 pandemic, Elekta was committed to innovating remote-access software solutions that help to ensure the safe and effective delivery of radiotherapy. These solutions include software systems as well as customer care and support services.
Today, Elekta is leveraging these capabilities in new ways to help customers continue to provide optimum treatments to their patients during the COVID-19 pandemic, which has disrupted almost every aspect of healthcare, including radiation therapy.[More information]
At Varian, we know you are faced with numerous challenges as you continue to treat patients during this pandemic. You are dealing with demands such as new remote work environments, the need to reduce unnecessary onsite patient visits, staffing reductions, and the challenge of tracking COVID-19-positive patients.[More information]
During these difficult and trying times of the COVID19 pandemic, Accuray has come together with its customers to provide innovative ways to assist them to be able to continue to care for their cancer patients.
As one initiative, Accuray’s Medical Affairs team is ready to provide customers with information regarding peer reviewed, published clinical literature. While its customers may be experiencing staff disruptions and shortages in qualified clinical staff, Accuray provides remote product training and clinical application’s support, a benefit of Accuray’s service agreements, to quickly train and educate new users.[More information]
As the demand and ambition for SRS and SBRT grow, Elekta is dedicated to make advanced treatments more personalized, operationally efficient and accessible to all patients around the world.[More information]
Elekta continues to push the boundaries of stereotactic treatment and provide solutions that meet the clinical needs of today and tomorrow.
Tracking Tumors with Calypso at The University Of Kansas Cancer Center: “Like Working In The Light”
When the University of Kansas Cancer Center (KUCC) acquired a linear accelerator in 2013, Habeeb Saleh, Ph.D., DABR, the center’s chief of medical physics, requested that the purchase include Calypso™ technology for soft tissue stereotactic body radiotherapy (SBRT). His colleague, Zachary Collins, M.D., also advocated for Calypso based on its growing word-of-mouth reputation and reported advantages for tumor tracking.[More information]
End-to-end spatial accuracy of single-isocenter linac-based SRS for multiple brain metastases: An experimental 3D dose verification study using RTsafe´s PseudoPatientTM technology.[More information]
- [More information]